{
    "2020-06-05": [
        [
            {
                "time": "2020-03-15",
                "original_text": "Antibody Drugs Could Help Curb the Pandemic. What Investors Need to Know.",
                "features": {
                    "keywords": [
                        "Antibody",
                        "Drugs",
                        "Pandemic",
                        "Investors"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-05",
                "original_text": "Cooper Companies (COO) Misses on Q2 Earnings and Revenues",
                "features": {
                    "keywords": [
                        "Cooper",
                        "Companies",
                        "Q2",
                        "Earnings",
                        "Revenues"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-20",
                "original_text": "Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "LLY",
                        "Coronavirus",
                        "Antibody",
                        "Phase I",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}